BCM
ABBV icon

Boone Capital Management’s AbbVie ABBV Stock Holding History

Boone Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-88,026
Closed -$11.9M – 14
2023
Q2 		$11.9M Hold
88,026
– – 4.26% 9
2023
Q1 		$14M Buy
88,026
+12,153
+16% +$1.86M 6.57% 9
2022
Q4 		$12.3M Buy
+75,873
New +$11.6M 6.29% 9

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Boone Capital Management's ABBV Position: Q3 2023 in Review

Boone Capital Management sold out of AbbVie (ABBV) in Q3 2023, closing a stake of 88,026 shares — an estimated $11.9M sold.

Boone Capital Management first reported a position in ABBV in Q4 2022 and held it in 3 quarters. The position peaked at $14M in Q1 2023. 3,109 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.

  • Boone Capital Management reported no remaining AbbVie position as of Q3 2023 after selling out during the quarter.
  • Boone Capital Management sold 88,026 AbbVie shares in Q3 2023, an estimated $11.9M.
  • Boone Capital Management first reported a position in AbbVie in Q4 2022 and held it in 3 quarters.
  • Boone Capital Management's AbbVie position peaked at $14M in Q1 2023.
  • 3,109 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.

Based on Boone Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.